Key Takeaways OPRX posted 11% revenue growth and $1.5M adjusted EBITDA, its best Q1 showing to date. 80% of OPRX's FY25 revenue guidance is covered by contracts; subscription share exceeds 5%. OPRX's Gross margin dipped to 60.9% as a lower-margin DTC mix weighed on profitability.OptimizeRx (OPRX) kicked off 2025 with strong momentum, delivering 11% year-over-year revenue growth to $21.9 million and turning in $1.5 million in adjusted EBITDA, its strongest first-quarter performance to date. The digital hea ...

Core Insights - Astellas has selected Veeva Vault CRM globally and Veeva China CRM for its operations in China, aiming to enhance commercial agility and execution [1][2] - The collaboration with Veeva is expected to provide Astellas with technology solutions and data that align with its mission to deliver transformative therapies for patients [2] - Vault CRM is designed to meet the unique and evolving business needs and compliance requirements of the life sciences industry, facilitating seamless collaboration among sales, marketing, and medical teams [2] Company Overview - Veeva Systems is recognized as the global leader in cloud software for the life sciences sector, serving over 1,000 customers, including major biopharmaceutical companies and emerging biotechs [3] - The company is committed to innovation, product excellence, and balancing the interests of all stakeholders, including customers, employees, and shareholders [3]